BackBaird Medical Investment Holdings Limited Overview

Baird Medical Investment Holdings Limited EBIT

Track Baird Medical Investment Holdings Limited's EBIT ($-15M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$846.81K
↑ 108.11% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$14.55M

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Baird Medical Investment Holdings Limited (BDMD) FAQ

As of the most recent data (June 2026), BDMD shows a EBIT of $-15M. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

The its sector sector average EBIT is about $2.4T. Baird Medical Investment Holdings Limited is at $-15M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how BDMD stacks up against individual peers as well.

Tracking BDMD's ebit over time shows whether Baird Medical Investment Holdings Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $-15M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Baird Medical Investment Holdings Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-15M) with ownership activity and broader fundamentals.